47 results on '"Holm, Hilma"'
Search Results
2. Loss-of-function variants in ITSN1 confer high risk of Parkinson's disease.
- Author
-
Skuladottir, Astros Th., Tragante, Vinicius, Sveinbjornsson, Gardar, Helgason, Hannes, Sturluson, Arni, Bjornsdottir, Anna, Jonsson, Palmi, Palmadottir, Vala, Sveinsson, Olafur A., Jensson, Brynjar O., Gudjonsson, Sigurjon A., Ivarsdottir, Erna V., Gisladottir, Rosa S., Gunnarsson, Arni F., Walters, G. Bragi, Jonsdottir, Gudrun A., Thorgeirsson, Thorgeir E., Bjornsdottir, Gyda, Holm, Hilma, and Gudbjartsson, Daniel F.
- Published
- 2024
- Full Text
- View/download PDF
3. Obesity Variants in the GIPR Gene Are not Associated With Risk of Fracture or Bone Mineral Density.
- Author
-
Styrkarsdottir, Unnur, Tragante, Vinicius, Stefansdottir, Lilja, Thorleifsson, Gudmar, Oddsson, Asmundur, Sørensen, Erik, Erikstrup, Christian, Schwarz, Peter, Jørgensen, Henrik Løvendahl, Lauritzen, Jes Bruun, Brunak, Søren, Knowlton, Kirk U, Nadauld, Lincoln D, Ullum, Henrik, Pedersen, Ole Birger Vesterager, Ostrowski, Sisse Rye, Holm, Hilma, Gudbjartsson, Daniel F, Sulem, Patrick, and Stefansson, Kari
- Subjects
BONE density ,BONE fractures ,DUAL-energy X-ray absorptiometry ,GENETIC variation ,VERTEBRAL fractures ,HIP fractures - Abstract
Context It is not clear if antagonizing the GIP (glucose-dependent insulinotropic polypeptide) receptor (GIPR) for treatment of obesity is likely to increase the risk of fractures, or to lower bone mineral density (BMD) beyond what is expected with rapid weight loss. Objective The objective of this study was to investigate the risk of fracture and BMD of sequence variants in GIPR that reduce the activity of the GIP receptor and have been associated with reduced body mass index (BMI). Methods We analyzed the association of 3 missense variants in GIPR , a common variant, rs1800437 (p.Glu354Gln), and 2 rare variants, rs139215588 (p.Arg190Gln) and rs143430880 (p.Glu288Gly), as well as a burden of predicted loss-of-function (LoF) variants with risk of fracture and with BMD in a large meta-analysis of up to 1.2 million participants. We analyzed associations with fractures at different skeletal sites in the general population: any fractures, hip fractures, vertebral fractures and forearm fractures, and specifically nonvertebral and osteoporotic fractures in postmenopausal women. We also evaluated associations with BMD at the lumbar spine, femoral neck, and total body measured with dual-energy x-ray absorptiometry (DXA), and with BMD estimated from heel ultrasound (eBMD). Results None of the 3 missense variants in GIPR was significantly associated with increased risk of fractures or with lower BMD. Burden of LoF variants in GIPR was not associated with fractures or with BMD measured with clinically validated DXA, but was associated with eBMD. Conclusion Missense variants in GIPR , or burden of LoF variants in the gene, are not associated with risk of fractures or with lower BMD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Polygenic risk scores associate with blood pressure traits across the lifespan.
- Author
-
Øvretveit, Karsten, Ingeström, Emma M L, Spitieris, Michail, Tragante, Vinicius, Wade, Kaitlin H, Thomas, Laurent F, Wolford, Brooke N, Wisløff, Ulrik, Gudbjartsson, Daniel F, Holm, Hilma, Stefansson, Kari, Brumpton, Ben M, and Hveem, Kristian
- Published
- 2024
- Full Text
- View/download PDF
5. Predicting the presence of coronary plaques featuring high-risk characteristics using polygenic risk scores and targeted proteomics in patients with suspected coronary artery disease.
- Author
-
Møller, Peter Loof, Rohde, Palle Duun, Dahl, Jonathan Nørtoft, Rasmussen, Laust Dupont, Nissen, Louise, Schmidt, Samuel Emil, McGilligan, Victoria, Gudbjartsson, Daniel F., Stefansson, Kari, Holm, Hilma, Bentzon, Jacob Fog, Bøttcher, Morten, Winther, Simon, and Nyegaard, Mette
- Subjects
CORONARY artery disease ,PROTEOMICS ,CORONARY artery stenosis ,PATIENT selection ,GENETIC variation - Abstract
Background: The presence of coronary plaques with high-risk characteristics is strongly associated with adverse cardiac events beyond the identification of coronary stenosis. Testing by coronary computed tomography angiography (CCTA) enables the identification of high-risk plaques (HRP). Referral for CCTA is presently based on pre-test probability estimates including clinical risk factors (CRFs); however, proteomics and/or genetic information could potentially improve patient selection for CCTA and, hence, identification of HRP. We aimed to (1) identify proteomic and genetic features associated with HRP presence and (2) investigate the effect of combining CRFs, proteomics, and genetics to predict HRP presence. Methods: Consecutive chest pain patients (n = 1462) undergoing CCTA to diagnose obstructive coronary artery disease (CAD) were included. Coronary plaques were assessed using a semi-automatic plaque analysis tool. Measurements of 368 circulating proteins were obtained with targeted Olink panels, and DNA genotyping was performed in all patients. Imputed genetic variants were used to compute a multi-trait multi-ancestry genome-wide polygenic score (GPS
Mult ). HRP presence was defined as plaques with two or more high-risk characteristics (low attenuation, spotty calcification, positive remodeling, and napkin ring sign). Prediction of HRP presence was performed using the glmnet algorithm with repeated fivefold cross-validation, using CRFs, proteomics, and GPSMult as input features. Results: HRPs were detected in 165 (11%) patients, and 15 input features were associated with HRP presence. Prediction of HRP presence based on CRFs yielded a mean area under the receiver operating curve (AUC) ± standard error of 73.2 ± 0.1, versus 69.0 ± 0.1 for proteomics and 60.1 ± 0.1 for GPSMult . Combining CRFs with GPSMult increased prediction accuracy (AUC 74.8 ± 0.1 (P = 0.004)), while the inclusion of proteomics provided no significant improvement to either the CRF (AUC 73.2 ± 0.1, P = 1.00) or the CRF + GPSMult (AUC 74.6 ± 0.1, P = 1.00) models, respectively. Conclusions: In patients with suspected CAD, incorporating genetic data with either clinical or proteomic data improves the prediction of high-risk plaque presence. Trial registration: https://clinicaltrials.gov/ct2/show/NCT02264717 (September 2014). [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. Screening for Rare Coding Variants That Associate With the QTc Interval in Iceland.
- Author
-
Sveinbjornsson, Gardar, Benediktsdottir, Bara D., Sigfusson, Gunnlaugur, Norland, Kristjan, Davidsson, Olafur B., Thorolfsdottir, Rosa B., Tragante, Vinicius, Arnadottir, Gudny A., Jensson, Brynjar O., Katrinardottir, Hildigunnur, Fridriksdottir, Run, Gudmundsdottir, Hallbera, Aegisdottir, Hildur M., Fridriksson, Brynjar, Thorgeirsson, Gudmundur, Magnusson, Vidar, Oddsson, Asmundur, Sulem, Patrick, Gudbjartsson, Daniel F., and Holm, Hilma
- Published
- 2023
- Full Text
- View/download PDF
7. Thirty novel sequence variants impacting human intracranial volume.
- Author
-
Nawaz, Muhammad Sulaman, Einarsson, Gudmundur, Bustamante, Mariana, Gisladottir, Rosa S., Walters, G. Bragi, Jonsdottir, Gudrun A., Skuladottir, Astros Th., Bjornsdottir, Gyda, Magnusson, Sigurdur H., Asbjornsdottir, Bergrun, Unnsteinsdottir, Unnur, Sigurdsson, Engilbert, Jonsson, Palmi V., Palmadottir, Vala Kolbrun, Gudjonsson, Sigurjon A., Halldorsson, Gisli H., Ferkingstad, Egil, Jonsdottir, Ingileif, Thorleifsson, Gudmar, and Holm, Hilma
- Published
- 2022
- Full Text
- View/download PDF
8. Genomic risk scores, biomolecules, and clinical conditions to predict atrial fibrillation: time to integrate what we can measure.
- Author
-
Kääb, Stefan, Holm, Hilma, and Kirchhof, Paulus
- Subjects
ATRIAL fibrillation ,DISEASE risk factors ,ATRIAL flutter ,BIOMOLECULES - Abstract
The irregular pulse that we now call atrial fibrillation (AF) was first described in 1628 by William Harvey in his I Exercitatio de Motu Cordis i .[1] A few centuries later, Einthoven first recorded AF on the electrocardiogram. Therefore, accounting for clinical risk factors is not expected to affect its association with AF and hence its predictive value.[4] The study participants had established cardiovascular conditions and were therefore at higher risk of incident AF, reflected in a relatively high 3-year incidence rate of AF of 3.6%. P.K. is listed as inventor on two patents held by University of Birmingham (Atrial Fibrillation Therapy WO 2015140571, Markers for Atrial Fibrillation WO 2016012783). [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
9. The CRTAC1 Protein in Plasma Is Associated With Osteoarthritis and Predicts Progression to Joint Replacement: A Large‐Scale Proteomics Scan in Iceland.
- Author
-
Styrkarsdottir, Unnur, Lund, Sigrun H., Saevarsdottir, Saedis, Magnusson, Magnus I., Gunnarsdottir, Kristbjorg, Norddahl, Gudmundur L., Frigge, Michael L., Ivarsdottir, Erna V., Bjornsdottir, Gyda, Holm, Hilma, Thorgeirsson, Gudmundur, Rafnar, Thorunn, Jonsdottir, Ingileif, Ingvarsson, Thorvaldur, Jonsson, Helgi, Sulem, Patrick, Thorsteinsdottir, Unnur, Gudbjartsson, Daniel, and Stefansson, Kari
- Subjects
BLOOD testing ,DISEASE progression ,BLOOD ,BIOMARKERS ,BLOOD proteins ,CONFIDENCE intervals ,AGE distribution ,CASE-control method ,BLOOD collection ,ARTIFICIAL joints ,PROTEOMICS ,SEX distribution ,OSTEOARTHRITIS ,DESCRIPTIVE statistics ,ODDS ratio ,BODY mass index ,LONGITUDINAL method ,DISEASE risk factors - Abstract
Objective: Biomarkers for diagnosis and progression of osteoarthritis (OA) are lacking. This study was undertaken to identify circulating biomarkers for OA that could predict disease occurrence and/or progression to joint replacement. Methods: Using the SomaScan platform, we measured 4,792 proteins in plasma from 37,278 individuals, of whom 12,178 individuals had OA and 2,524 had undergone joint replacement. We performed a case–control study for identification of potential protein biomarkers for hip, knee, and/or hand OA, and a prospective study for identification of biomarkers for joint replacement. Results: Among the large panel of plasma proteins assessed, cartilage acidic protein 1 (CRTAC1) was the most strongly associated with both OA diagnosis (odds ratio 1.46 [95% confidence interval 1.41–1.52] for knee OA, odds ratio 1.36 [95% confidence interval 1.29–1.43] for hip OA, and odds ratio 1.33 [95% confidence interval 1.26–1.40] for hand OA) and progression to joint replacement (hazard ratio 1.40 [95% confidence interval 1.30–1.51] for knee replacement and hazard ratio 1.31 [95% confidence interval 1.19–1.45] for hip replacement). Patients with OA who were in the highest quintile of risk of joint replacement, based on known risk factors (i.e., age, sex, and body mass index) and plasma CRTAC1 level, were 16 times more likely to undergo knee replacement within 5 years of plasma sample collection than those in the lowest quintile, and 6.5 times more likely to undergo hip replacement. CRTAC1 was not associated with other types of inflammatory arthritis. A specific protein profile was identified in those patients who had undergone joint replacement prior to plasma sample collection. Conclusion: Through a hypothesis‐free approach, we identified CRTAC1 in plasma as a novel promising candidate biomarker for OA that is both associated with occurrence of OA and predictive of progression to joint replacement. This biomarker might also be useful in the selection of suitable patients for clinical trial enrollment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Predicting the probability of death using proteomics.
- Author
-
Eiriksdottir, Thjodbjorg, Ardal, Steinthor, Jonsson, Benedikt A., Lund, Sigrun H., Ivarsdottir, Erna V., Norland, Kristjan, Ferkingstad, Egil, Stefansson, Hreinn, Jonsdottir, Ingileif, Holm, Hilma, Rafnar, Thorunn, Saemundsdottir, Jona, Norddahl, Gudmundur L., Thorgeirsson, Gudmundur, Gudbjartsson, Daniel F., Sulem, Patrick, Thorsteinsdottir, Unnur, Stefansson, Kari, and Ulfarsson, Magnus O.
- Subjects
MORTALITY risk factors ,BLOOD proteins ,PROTEOMICS ,MEDICAL screening ,DATA analysis - Abstract
Predicting all-cause mortality risk is challenging and requires extensive medical data. Recently, large-scale proteomics datasets have proven useful for predicting health-related outcomes. Here, we use measurements of levels of 4,684 plasma proteins in 22,913 Icelanders to develop all-cause mortality predictors both for short- and long-term risk. The participants were 18-101 years old with a mean follow up of 13.7 (sd. 4.7) years. During the study period, 7,061 participants died. Our proposed predictor outperformed, in survival prediction, a predictor based on conventional mortality risk factors. We could identify the 5% at highest risk in a group of 60-80 years old, where 88% died within ten years and 5% at the lowest risk where only 1% died. Furthermore, the predicted risk of death correlates with measures of frailty in an independent dataset. Our results show that the plasma proteome can be used to assess general health and estimate the risk of death. Eiriksdottir et al. use a temporal proteomic dataset from over 22,000 Icelandic individuals to identify predictors and predict all-cause mortality. Their findings suggest that the plasma proteome may be of value in general health screening for risk of death. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Molecular benchmarks of a SARS-CoV-2 epidemic.
- Author
-
Jonsson, Hakon, Magnusson, Olafur T., Melsted, Pall, Berglund, Jonas, Agustsdottir, Arna B., Eiríksdottir, Berglind, Fridriksdottir, Run, Garðarsdottir, Elisabet Eir, Georgsson, Gudmundur, Gretarsdottir, Olafia S., Guðmundsson, Kjartan R., Gunnarsdottir, Thora Rosa, Eggertsson, Hannes, Gylfason, Arnaldur, Holm, Hilma, Jensson, Brynjar O., Jonasdottir, Aslaug, Jonsson, Frosti, Josefsdottir, Kamilla S., and Thordardottir, Marianna
- Subjects
SARS-CoV-2 ,VIRAL transmission ,EPIDEMICS ,VIRAL mutation - Abstract
A pressing concern in the SARS-CoV-2 epidemic and other viral outbreaks, is the extent to which the containment measures are halting the viral spread. A straightforward way to assess this is to tally the active cases and the recovered ones throughout the epidemic. Here, we show how epidemic control can be assessed with molecular information during a well characterized epidemic in Iceland. We demonstrate how the viral concentration decreased in those newly diagnosed as the epidemic transitioned from exponential growth phase to containment phase. The viral concentration in the cases identified in population screening decreased faster than in those symptomatic and considered at high risk and that were targeted by the healthcare system. The viral concentration persists in recovering individuals as we found that half of the cases are still positive after two weeks. We demonstrate that accumulation of mutations in SARS-CoV-2 genome can be exploited to track the rate of new viral generations throughout the different phases of the epidemic, where the accumulation of mutations decreases as the transmission rate decreases in the containment phase. Overall, the molecular signatures of SARS-CoV-2 infections contain valuable epidemiological information that can be used to assess the effectiveness of containment measures. The concentration of SARS-CoV-2 changes during an individual's infection, and mutations accumulate as viruses are transmitted between people. Here, the authors use data from Iceland to demonstrate how this information can be exploited at the population-level to determine the phase of the epidemic. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. The genetic architecture of age-related hearing impairment revealed by genome-wide association analysis.
- Author
-
Ivarsdottir, Erna V., Holm, Hilma, Benonisdottir, Stefania, Olafsdottir, Thorhildur, Sveinbjornsson, Gardar, Thorleifsson, Gudmar, Eggertsson, Hannes P., Halldorsson, Gisli H., Hjorleifsson, Kristjan E., Melsted, Pall, Gylfason, Arnaldur, Arnadottir, Gudny A., Oddsson, Asmundur, Jensson, Brynjar O., Jonasdottir, Aslaug, Jonasdottir, Adalbjorg, Juliusdottir, Thorhildur, Stefansdottir, Lilja, Tragante, Vinicius, and Halldorsson, Bjarni V.
- Subjects
HEARING impaired ,COMMON sense ,OLDER people ,EXONS (Genetics) ,GENOMES - Abstract
Age-related hearing impairment (ARHI) is the most common sensory disorder in older adults. We conducted a genome-wide association meta-analysis of 121,934 ARHI cases and 591,699 controls from Iceland and the UK. We identified 21 novel sequence variants, of which 13 are rare, under either additive or recessive models. Of special interest are a missense variant in LOXHD1 (MAF = 1.96%) and a tandem duplication in FBF1 covering 4 exons (MAF = 0.22%) associating with ARHI (OR = 3.7 for homozygotes, P = 1.7 × 10
−22 and OR = 4.2 for heterozygotes, P = 5.7 × 10−27 , respectively). We constructed an ARHI genetic risk score (GRS) using common variants and showed that a common variant GRS can identify individuals at risk comparable to carriers of rare high penetrance variants. Furthermore, we found that ARHI and tinnitus share genetic causes. This study sheds a new light on the genetic architecture of ARHI, through several rare variants in both Mendelian deafness genes and genes not previously linked to hearing. Erna Ivarsdottir et al. report a genome-wide association meta-analysis for age-related hearing loss in the Icelandic and UK populations. They identify 21 novel variants, 13 of which are rare, and reveal a genetic correlation between age-related hearing loss and tinnitus. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
13. Genetic Risk of Coronary Artery Disease, Features of Atherosclerosis, and Coronary Plaque Burden.
- Author
-
Christiansen, Morten Krogh, Nissen, Louise, Winther, Simon, Møller, Peter Loof, Frost, Lars, Johansen, Jane Kirk, Jensen, Henrik Kjærulf, Guðbjartsson, Daníel, Holm, Hilma, Stefánsson, Kári, Bøtker, Hans Erik, Bøttcher, Morten, and Nyegaard, Mette
- Published
- 2020
- Full Text
- View/download PDF
14. Sequence variation at ANAPC1 accounts for 24% of the variability in corneal endothelial cell density.
- Author
-
Ivarsdottir, Erna V., Benonisdottir, Stefania, Thorleifsson, Gudmar, Sulem, Patrick, Oddsson, Asmundur, Styrkarsdottir, Unnur, Kristmundsdottir, Snaedis, Arnadottir, Gudny A., Thorgeirsson, Gudmundur, Jonsdottir, Ingileif, Zoega, Gunnar M., Thorsteinsdottir, Unnur, Gudbjartsson, Daniel F., Jonasson, Fridbert, Holm, Hilma, and Stefansson, Kari
- Abstract
The corneal endothelium is vital for transparency and proper hydration of the cornea. Here, we conduct a genome-wide association study of corneal endothelial cell density (cells/mm
2 ), coefficient of cell size variation (CV), percentage of hexagonal cells (HEX) and central corneal thickness (CCT) in 6,125 Icelanders and find associations at 10 loci, including 7 novel. We assess the effects of these variants on various ocular biomechanics such as corneal hysteresis (CH), as well as eye diseases such as glaucoma and corneal dystrophies. Most notably, an intergenic variant close to ANAPC1 (rs78658973[A], frequency = 28.3%) strongly associates with decreased cell density and accounts for 24% of the population variance in cell density (β = −0.77 SD, P = 1.8 × 10−314 ) and associates with increased CH (β = 0.19 SD, P = 2.6 × 10−19 ) without affecting risk of corneal diseases and glaucoma. Our findings indicate that despite correlations between cell density and eye diseases, low cell density does not increase the risk of disease. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
15. A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation.
- Author
-
Gudbjartsson, Daniel F., Holm, Hilma, Sulem, Patrick, Masson, Gisli, Oddsson, Asmundur, Magnusson, Olafur Th., Saemundsdottir, Jona, Helgadottir, Hafdis Th., Helgason, Hannes, Johannsdottir, Hrefna, Gretarsdottir, Solveig, Gudjonsson, Sigurjon A., Njølstad, Inger, Løchen, Maja-Lisa, Baum, Larry, Ma, Ronald C.W., Sigfusson, Gunnlaugur, Kong, Augustine, Thorgeirsson, Guðmundur, and Sverrisson, Jon Th.
- Abstract
Aims: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in man, causing substantial morbidity and mortality with a major worldwide public health impact. It is increasingly recognized as a highly heritable condition. This study aimed to determine genetic risk factors for early-onset AF. Methods and results; We sequenced the whole genomes of 8453 Icelanders and imputed genotypes of the 25.5 million sequence variants we discovered into 1799 Icelanders with early-onset AF (diagnosed before 60 years of age) and 337 453 controls. Each sequence variant was tested for association based on multiplicative and recessive inheritance models. We discovered a rare frameshift deletion in the myosin MYL4 gene (c.234delC) that associates with early-onset AF under a recessive mode of inheritance (allelic frequency¼0.58%). We found eight homozygous carriers of the mutation, all of whom had early-onset AF. Six of the homozygotes were diagnosed by the age of 30 and the remaining two in their 50s. Three of the homozygotes had received pacemaker implantations due to sick sinus syndrome, three had suffered an ischemic stroke, and one suffered sudden cardiac death. Conclusions: Through a population approach we found a loss of function mutation in the myosin gene MYL4 that, in the homozygous state, is completely penetrant for early-onset AF. The finding may provide novel mechanistic insight into the pathophysiology of this complex arrhythmia. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
16. Identification of a large set of rare complete human knockouts.
- Author
-
Sulem, Patrick, Oddson, Asmundur, Stefansson, Hreinn, Gudjonsson, Sigurjon A, Zink, Florian, Hjartarson, Eirikur, Sigurdsson, Gunnar Th, Jonasdottir, Adalbjorg, Jonasdottir, Aslaug, Sigurdsson, Asgeir, Magnusson, Olafur Th, Masson, Gisli, Helgason, Hannes, Kong, Augustine, Gudbjartsson, Daniel F, Helgason, Agnar, Holm, Hilma, Thorsteinsdottir, Unnur, and Stefansson, Kari
- Subjects
HUMAN genetics ,GENETIC disorders ,MICROBIAL mutation ,GENE fusion ,GENE mapping - Abstract
Loss-of-function mutations cause many mendelian diseases. Here we aimed to create a catalog of autosomal genes that are completely knocked out in humans by rare loss-of-function mutations. We sequenced the whole genomes of 2,636 Icelanders and imputed the sequence variants identified in this set into 101,584 additional chip-genotyped and phased Icelanders. We found a total of 6,795 autosomal loss-of-function SNPs and indels in 4,924 genes. Of the genotyped Icelanders, 7.7% are homozygotes or compound heterozygotes for loss-of-function mutations with a minor allele frequency (MAF) below 2% in 1,171 genes (complete knockouts). Genes that are highly expressed in the brain are less often completely knocked out than other genes. Homozygous loss-of-function offspring of two heterozygous parents occurred less frequently than expected (deficit of 136 per 10,000 transmissions for variants with MAF <2%, 95% confidence interval (CI) = 10-261). [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
17. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community.
- Author
-
Kaess, Bernhard M., Preis, Sarah R., Lieb, Wolfgang, Beiser, Alexa S., Yang, Qiong, Chen, Tai C., Hengstenberg, Christian, Erdmann, Jeanette, Schunkert, Heribert, Seshadri, Sudha, Vasan, Ramachandran S., CARDIoGRAM, Assimes, Themistocles L, Deloukas, Panos, Holm, Hilma, Kathiresan, Sekar, König, Inke R, McPherson, Ruth, Reilly, Muredach P, and Roberts, Robert
- Published
- 2015
- Full Text
- View/download PDF
18. Rare mutations associating with serum creatinine and chronic kidney disease.
- Author
-
Sveinbjornsson, Gardar, Mikaelsdottir, Evgenia, Palsson, Runolfur, Indridason, Olafur S., Holm, Hilma, Jonasdottir, Aslaug, Helgason, Agnar, Sigurdsson, Snaevar, Jonasdottir, Adalbjorg, Sigurdsson, Asgeir, Eyjolfsson, Gudmundur Ingi, Sigurdardottir, Olof, Magnusson, Olafur Th., Kong, Augustine, Masson, Gisli, Sulem, Patrick, Olafsson, Isleifur, Thorsteinsdottir, Unnur, Gudbjartsson, Daniel F., and Stefansson, Kari
- Published
- 2014
- Full Text
- View/download PDF
19. Nationwide Study on Hypertrophic Cardiomyopathy in Iceland.
- Author
-
Adalsteinsdottir, Berglind, Teekakirikul, Polakit, Maron, Barry J., Burke, Michael A., Gudbjartsson, Daniel F., Holm, Hilma, Stefansson, Kari, DePalma, Steven R., Mazaika, Erica, McDonough, Barbara, Danielsen, Ragnar, Seidman, Jonathan G., Seidman, Christine E., and Gunnarsson, Gunnar T.
- Published
- 2014
- Full Text
- View/download PDF
20. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders.
- Author
-
den Hoed, Marcel, Eijgelsheim, Mark, Esko, Tõnu, Brundel, Bianca J J M, Peal, David S, Evans, David M, Nolte, Ilja M, Segrè, Ayellet V, Holm, Hilma, Handsaker, Robert E, Westra, Harm-Jan, Johnson, Toby, Isaacs, Aaron, Yang, Jian, Lundby, Alicia, Zhao, Jing Hua, Kim, Young Jin, Go, Min Jin, Almgren, Peter, and Bochud, Murielle
- Subjects
HEART beat ,CARDIOVASCULAR diseases ,DANIO ,DROSOPHILA melanogaster - Abstract
Elevated resting heart rate is associated with greater risk of cardiovascular disease and mortality. In a 2-stage meta-analysis of genome-wide association studies in up to 181,171 individuals, we identified 14 new loci associated with heart rate and confirmed associations with all 7 previously established loci. Experimental downregulation of gene expression in Drosophila melanogaster and Danio rerio identified 20 genes at 11 loci that are relevant for heart rate regulation and highlight a role for genes involved in signal transmission, embryonic cardiac development and the pathophysiology of dilated cardiomyopathy, congenital heart failure and/or sudden cardiac death. In addition, genetic susceptibility to increased heart rate is associated with altered cardiac conduction and reduced risk of sick sinus syndrome, and both heart rate-increasing and heart rate-decreasing variants associate with risk of atrial fibrillation. Our findings provide fresh insights into the mechanisms regulating heart rate and identify new therapeutic targets. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
21. Rare mutations associating with serum creatinine and chronic kidney disease.
- Author
-
Sveinbjornsson, Gardar, Mikaelsdottir, Evgenia, Palsson, Runolfur, Indridason, Olafur S., Holm, Hilma, Jonasdottir, Aslaug, Helgason, Agnar, Sigurdsson, Snaevar, Jonasdottir, Adalbjorg, Sigurdsson, Asgeir, Eyjolfsson, Gudmundur Ingi, Sigurdardottir, Olof, Magnusson, Olafur Th., Kong, Augustine, Masson, Gisli, Sulem, Patrick, Olafsson, Isleifur, Thorsteinsdottir, Unnur, Gudbjartsson, Daniel F., and Stefansson, Kari
- Published
- 2012
- Full Text
- View/download PDF
22. Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication Bias.
- Author
-
Clarke, Robert, Bennett, Derrick A., Parish, Sarah, Verhoef, Petra, Dötsch-Klerk, Mariska, Lathrop, Mark, Xu, Peng, Nordestgaard, Børge G., Holm, Hilma, Hopewell, Jemma C., Saleheen, Danish, Tanaka, Toshihiro, Anand, Sonia S., Chambers, John C., Kleber, Marcus E., Ouwehand, Willem H., Yamada, Yoshiji, Elbers, Clara, Peters, Bas, and Stewart, Alexandre F. R.
- Subjects
HOMOCYSTEINE ,GENETIC polymorphisms ,CORONARY disease ,META-analysis ,CASE-control method - Abstract
Background: Moderately elevated blood levels of homocysteine are weakly correlated with coronary heart disease (CHD) risk, but causality remains uncertain. When folate levels are low, the TT genotype of the common C677T polymorphism (rs1801133) of the methylene tetrahydrofolate reductase gene (MTHFR) appreciably increases homocysteine levels, so ''Mendelian randomization'' studies using this variant as an instrumental variable could help test causality. Methods and Findings: Nineteen unpublished datasets were obtained (total 48,175 CHD cases and 67,961 controls) in which multiple genetic variants had been measured, including MTHFR C677T. These datasets did not include measurements of blood homocysteine, but homocysteine levels would be expected to be about 20% higher with TT than with CC genotype in the populations studied. In meta-analyses of these unpublished datasets, the case-control CHD odds ratio (OR) and 95% CI comparing TT versus CC homozygotes was 1.02 (0.98-1.07; p = 0.28) overall, and 1.01 (0.95-1.07) in unsupplemented low-folate populations. By contrast, in a slightly updated meta-analysis of the 86 published studies (28,617 CHD cases and 41,857 controls), the OR was 1.15 (1.09-1.21), significantly discrepant (p = 0.001) with the OR in the unpublished datasets. Within the meta-analysis of published studies, the OR was 1.12 (1.04-1.21) in the 14 larger studies (those with variance of log OR,0.05; total 13,119 cases) and 1.18 (1.09-1.28) in the 72 smaller ones (total 15,498 cases). Conclusions: The CI for the overall result from large unpublished datasets shows lifelong moderate homocysteine elevation has little or no effect on CHD. The discrepant overall result from previously published studies reflects publication bias or methodological problems. [ABSTRACT FROM AUTHOR]
- Published
- 2012
23. Identification of low-frequency variants associated with gout and serum uric acid levels.
- Author
-
Sulem, Patrick, Gudbjartsson, Daniel F, Walters, G Bragi, Helgadottir, Hafdis T, Helgason, Agnar, Gudjonsson, Sigurjon A, Zanon, Carlo, Besenbacher, Soren, Bjornsdottir, Gyda, Magnusson, Olafur T, Magnusson, Gisli, Hjartarson, Eirikur, Saemundsdottir, Jona, Gylfason, Arnaldur, Jonasdottir, Adalbjorg, Holm, Hilma, Karason, Ari, Rafnar, Thorunn, Stefansson, Hreinn, and Andreassen, Ole A
- Subjects
GOUT ,SERUM ,URIC acid ,HUMAN genome ,GENE frequency ,GENOTYPE-environment interaction - Abstract
We tested 16 million SNPs, identified through whole-genome sequencing of 457 Icelanders, for association with gout and serum uric acid levels. Genotypes were imputed into 41,675 chip-genotyped Icelanders and their relatives, for effective sample sizes of 968 individuals with gout and 15,506 individuals for whom serum uric acid measurements were available. We identified a low-frequency missense variant (c.1580C>G) in ALDH16A1 associated with gout (OR = 3.12, P = 1.5 × 10
?16 , at-risk allele frequency = 0.019) and serum uric acid levels (effect = 0.36 s.d., P = 4.5 × 10?21 ). We confirmed the association with gout by performing Sanger sequencing on 6,017 Icelanders. The association with gout was stronger in males relative to females. We also found a second variant on chromosome 1 associated with gout (OR = 1.92, P = 0.046, at-risk allele frequency = 0.986) and serum uric acid levels (effect = 0.48 s.d., P = 4.5 × 10?16 ). This variant is close to a common variant previously associated with serum uric acid levels. This work illustrates how whole-genome sequencing data allow the detection of associations between low-frequency variants and complex traits. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
24. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.
- Author
-
Chambers, John C, Zhang, Weihua, Sehmi, Joban, Li, Xinzhong, Wass, Mark N, Van der Harst, Pim, Holm, Hilma, Sanna, Serena, Kavousi, Maryam, Baumeister, Sebastian E, Coin, Lachlan J, Deng, Guohong, Gieger, Christian, Heard-Costa, Nancy L, Hottenga, Jouke-Jan, Kühnel, Brigitte, Kumar, Vinod, Lagou, Vasiliki, Liang, Liming, and Luan, Jian'an
- Subjects
LIVER diseases ,ENZYMES ,GENOMICS ,GENE expression ,ADENOSINE triphosphate ,LIPID metabolism ,CARBOHYDRATE metabolism - Abstract
Concentrations of liver enzymes in plasma are widely used as indicators of liver disease. We carried out a genome-wide association study in 61,089 individuals, identifying 42 loci associated with concentrations of liver enzymes in plasma, of which 32 are new associations (P = 10
?8 to P = 10?190 ). We used functional genomic approaches including metabonomic profiling and gene expression analyses to identify probable candidate genes at these regions. We identified 69 candidate genes, including genes involved in biliary transport (ATP8B1 and ABCB11), glucose, carbohydrate and lipid metabolism (FADS1, FADS2, GCKR, JMJD1C, HNF1A, MLXIPL, PNPLA3, PPP1R3B, SLC2A2 and TRIB1), glycoprotein biosynthesis and cell surface glycobiology (ABO, ASGR1, FUT2, GPLD1 and ST3GAL4), inflammation and immunity (CD276, CDH6, GCKR, HNF1A, HPR, ITGA1, RORA and STAT4) and glutathione metabolism (GSTT1, GSTT2 and GGT), as well as several genes of uncertain or unknown function (including ABHD12, EFHD1, EFNA1, EPHA2, MICAL3 and ZNF827). Our results provide new insight into genetic mechanisms and pathways influencing markers of liver function. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
25. Sequence variants at CYP1A1–CYP1A2 and AHR associate with coffee consumption.
- Author
-
Sulem, Patrick, Gudbjartsson, Daniel F., Geller, Frank, Prokopenko, Inga, Feenstra, Bjarke, Aben, Katja K.H., Franke, Barbara, den Heijer, Martin, Kovacs, Peter, Stumvoll, Michael, Mägi, Reedik, Yanek, Lisa R., Becker, Lewis C., Boyd, Heather A., Stacey, Simon N., Walters, G. Bragi, Jonasdottir, Adalbjorg, Thorleifsson, Gudmar, Holm, Hilma, and Gudjonsson, Sigurjon A.
- Published
- 2011
- Full Text
- View/download PDF
26. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.
- Author
-
Schunkert, Heribert, König, Inke R., Kathiresan, Sekar, Reilly, Muredach P., Assimes, Themistocles L., Holm, Hilma, Preuss, Michael, Stewart, Alexandre F. R., Barbalic, Maja, Gieger, Christian, Absher, Devin, Aherrahrou, Zouhair, Allayee, Hooman, Altshuler, David, Anand, Sonia S, Andersen, Karl, Anderson, Jeffrey L., Ardissino, Diego, Ball, Stephen G., and Balmforth, Anthony J.
- Subjects
CORONARY disease ,GENE frequency ,GENOMES ,CHROMOSOME replication ,GASTRIC bypass ,LIPOPROTEINS ,META-analysis - Abstract
We performed a meta-analysis of 14 genome-wide association studies of coronary artery disease (CAD) comprising 22,233 individuals with CAD (cases) and 64,762 controls of European descent followed by genotyping of top association signals in 56,682 additional individuals. This analysis identified 13 loci newly associated with CAD at P < 5 × 10
?8 and confirmed the association of 10 of 12 previously reported CAD loci. The 13 new loci showed risk allele frequencies ranging from 0.13 to 0.91 and were associated with a 6% to 17% increase in the risk of CAD per allele. Notably, only three of the new loci showed significant association with traditional CAD risk factors and the majority lie in gene regions not previously implicated in the pathogenesis of CAD. Finally, five of the new CAD risk loci appear to have pleiotropic effects, showing strong association with various other human diseases or traits. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
27. A rare variant in MYH6 is associated with high risk of sick sinus syndrome.
- Author
-
Holm, Hilma, Gudbjartsson, Daniel F., Sulem, Patrick, Masson, Gisli, Helgadottir, Hafdis Th, Zanon, Carlo, Magnusson, Olafur Th, Helgason, Agnar, Saemundsdottir, Jona, Gylfason, Arnaldur, Stefansdottir, Hrafnhildur, Gretarsdottir, Solveig, Matthiasson, Stefan E., Thorgeirsson, Guðmundur, Jonasdottir, Aslaug, Sigurdsson, Asgeir, Stefansson, Hreinn, Werge, Thomas, Rafnar, Thorunn, and Kiemeney, Lambertus A.
- Subjects
SICK sinus syndrome ,MYOSIN ,BRADYCARDIA ,TACHYARRHYTHMIAS ,ATRIAL fibrillation ,ION channels - Abstract
Through complementary application of SNP genotyping, whole-genome sequencing and imputation in 38,384 Icelanders, we have discovered a previously unidentified sick sinus syndrome susceptibility gene, MYH6, encoding the alpha heavy chain subunit of cardiac myosin. A missense variant in this gene, c.2161C>T, results in the conceptual amino acid substitution p.Arg721Trp, has an allelic frequency of 0.38% in Icelanders and associates with sick sinus syndrome with an odds ratio = 12.53 and P = 1.5 × 10
?29 . We show that the lifetime risk of being diagnosed with sick sinus syndrome is around 6% for non-carriers of c.2161C>T but is approximately 50% for carriers of the c.2161C>T variant. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
28. Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels.
- Author
-
Gudmundsson, Julius, Besenbacher, Soren, Sulem, Patrick, Gudbjartsson, Daniel F., Olafsson, Isleifur, Arinbjarnarson, Sturla, Agnarsson, Bjarni A., Benediktsdottir, Kristrun R., Isaksson, Helgi J., Kostic, Jelena P., Gudjonsson, Sigurjon A., Stacey, Simon N., Gylfason, Arnaldur, Sigurdsson, Asgeir, Holm, Hilma, Bjornsdottir, Unnur S., Eyjolfsson, Gudmundur I., Navarrete, Sebastian, Fuertes, Fernando, and Garcia-Prats, Maria D.
- Published
- 2010
- Full Text
- View/download PDF
29. The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease.
- Author
-
Patel, Riyaz S., Su, Shaoyong, Neeland, Ian J., Ahuja, Ayushi, Veledar, Emir, Zhao, Jinying, Helgadottir, Anna, Holm, Hilma, Gulcher, Jeffrey R., Stefansson, Kari, Waddy, Salina, Vaccarino, Viola, Zafari, A. Maziar, and Quyyumi, Arshed A.
- Abstract
Aims We tested the hypothesis that the 9p21 risk locus promotes atherosclerosis by examining the association between rs10757278 and coronary artery disease (CAD) severity and progression determined by semi-quantitative angiographic scores. Methods and results The rs10757278 single nucleotide polymorphism (SNP) was genotyped as the marker for the 9p21 locus in 2334 Caucasian patients undergoing cardiac catheterization (mean age 63, male 67%). Angiographic CAD was assessed using two semi-quantitative scoring systems with one estimating severity (Gensini) and the other extent (Sullivan). A subset of 308 patients who underwent two or more coronary angiograms at least 6 months apart were examined for net change in Gensini and Sullivan scores over time to determine the rate of CAD progression by genotype and were further classified as ‘progressors’ or ‘non-progressors’ based on absolute change per year in angiographic severity score. We replicated the association between the rs10757278 SNP and myocardial infarction and binary (presence/absence) angiographic classifications of CAD. Furthermore, we observed a significant additive association with this SNP, and both severity and extent of CAD using angiographic scores, after adjustment for age, gender, body mass index, traditional cardiovascular risk factors, myocardial infarction, and statin use (Gensini P = 0.016, Sullivan P = 0.005). In addition, there was a significant linear association with CAD progression before and after adjustment for covariates (Gensini P = 0.023, Sullivan P = 0.003) with homozygotes for the risk variant having three-fold greater odds of CAD progression compared with the referent group. Conclusion The 9p21 risk locus is associated with angiographically defined severity, extent, and progression of CAD, suggesting a role for this locus in influencing atherosclerosis and its progression. [ABSTRACT FROM PUBLISHER]
- Published
- 2010
- Full Text
- View/download PDF
30. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study.
- Author
-
Preuss, Michael, König, Inke R., Thompson, John R., Erdmann, Jeanette, Absher, Devin, Assimes, Themistocles L., Blankenberg, Stefan, Boerwinkle, Eric, Li Chen, Cupples, L. Adrienne, Hall, Alistair S., Halperin, Eran, Hengstenberg, Christian, Holm, Hilma, Laaksonen, Reijo, Mingyao Li, März, Winfried, McPherson, Ruth, Musunuru, Kiran, and Nelson, Christopher P.
- Published
- 2010
- Full Text
- View/download PDF
31. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.
- Author
-
Gretarsdottir, Solveig, Baas, Annette F., Thorleifsson, Gudmar, Holm, Hilma, den Heijer, Martin, de Vries, Jean-Paul P. M., Kranendonk, Steef E., Zeebregts, Clark J. A. M., van Sterkenburg, Steven M., Geelkerken, Robert H., van Rij, Andre M., Williams, Michael J. A., Boll, Albert P. M., Kostic, Jelena P., Jonasdottir, Adalbjorg, Jonasdottir, Aslaug, Walters, G. Bragi, Masson, Gisli, Sulem, Patrick, and Saemundsdottir, Jona
- Subjects
ABDOMINAL aorta ,ANEURYSMS ,GENE frequency ,MYOCARDIAL infarction ,CARDIOVASCULAR diseases ,PULMONARY embolism ,GENETICS ,DISEASES - Abstract
We performed a genome-wide association study on 1,292 individuals with abdominal aortic aneurysms (AAAs) and 30,503 controls from Iceland and The Netherlands, with a follow-up of top markers in up to 3,267 individuals with AAAs and 7,451 controls. The A allele of rs7025486 on 9q33 was found to associate with AAA, with an odds ratio (OR) of 1.21 and P = 4.6 × 10
−10 . In tests for association with other vascular diseases, we found that rs7025486[A] is associated with early onset myocardial infarction (OR = 1.18, P = 3.1 × 10−5 ), peripheral arterial disease (OR = 1.14, P = 3.9 × 10−5 ) and pulmonary embolism (OR = 1.20, P = 0.00030), but not with intracranial aneurysm or ischemic stroke. No association was observed between rs7025486[A] and common risk factors for arterial and venous diseases—that is, smoking, lipid levels, obesity, type 2 diabetes and hypertension. Rs7025486 is located within DAB2IP, which encodes an inhibitor of cell growth and survival. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
32. Association of Variants at UMOD with Chronic Kidney Disease and Kidney Stones-Role of Age and Comorbid Diseases.
- Author
-
Gudbjartsson, Daniel F., Holm, Hilma, Indridason, Olafur S., Thorleifsson, Gudmar, Edvardsson, Vidar, Sulem, Patrick, de Vegt, Femmie, d'Ancona, Frank C. H., den Heijer, Martin, Franzson, Leifur, Rafnar, Thorunn, Kristjansson, Kristleifur, Bjornsdottir, Unnur S., Eyjolfsson, Gudmundur I., Kiemeney, Lambertus A., Kong, Augustine, Palsson, Runolfur, Thorsteinsdottir, Unnur, and Stefansson, Kari
- Subjects
KIDNEY diseases ,DISEASES ,MORTALITY ,KIDNEY stones ,DIABETES ,HYPERTENSION - Abstract
Chronic kidney disease (CKD) is a worldwide public health problem that is associated with substantial morbidity and mortality. To search for sequence variants that associate with CKD, we conducted a genome-wide association study (GWAS) that included a total of 3,203 Icelandic cases and 38,782 controls. We observed an association between CKD and a variant with 80% population frequency, rs4293393-T, positioned next to the UMOD gene (GeneID: 7369) on chromosome 16p12 (OR = 1.25, P= 4.1×10
-10 ). This gene encodes uromodulin (Tamm-Horsfall protein), the most abundant protein in mammalian urine. The variant also associates significantly with serum creatinine concentration (SCr) in Icelandic subjects (N = 24,635, P= 1.3×10-23 ) but not in a smaller set of healthy Dutch controls (N = 1,819, P = 0.39). Our findings validate the association between the UMOD variant and both CKD and SCr recently discovered in a large GWAS. In the Icelandic dataset, we demonstrate that the effect on SCr increases substantially with both age (P= 3.0×10-17 ) and number of comorbid diseases (P = 0.008). The association with CKD is also stronger in the older age groups. These results suggest that the UMOD variant may influence the adaptation of the kidney to age-related risk factors of kidney disease such as hypertension and diabetes. The variant also associates with serum urea (P =1.0×10-6 ), uric acid (P = 0.0064), and suggestively with gout. In contrast to CKD, the UMOD variant confers protection against kidney stones when studied in 3,617 Icelandic and Dutch kidney stone cases and 43,201 controls (OR = 0.88, P= 5.7×10-5 ). [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
33. Genome-Wide Meta-Analysis for Serum Calcium Identifies Significantly Associated SNPs near the Calcium-Sensing Receptor (CASR ) Gene.
- Author
-
Kapur, Karen, Johnson, Toby, Beckmann, Noam D., Sehmi, Joban, Tanaka, Toshiko, Kutalik, Zoltán, Styrkarsdottir, Unnur, Weihua Zhang, Marek, Diana, Gudbjartsson, Daniel F., Milaneschi, Yuri, Holm, Hilma, DiIorio, Angelo, Waterworth, Dawn, Yun Li, Singleton, Andrew B., Bjornsdottir, Unnur S., Sigurdsson, Gunnar, Hernandez, Dena G., and DeSilva, Ranil
- Subjects
CALCIUM ,MINERAL metabolism ,CARDIOVASCULAR system ,META-analysis ,GENOMES ,GENETICS - Abstract
Calcium has a pivotal role in biological functions, and serum calcium levels have been associated with numerous disorders of bone and mineral metabolism, as well as with cardiovascular mortality. Here we report results from a genome-wide association study of serum calcium, integrating data from four independent cohorts including a total of 12,865 individuals of European and Indian Asian descent. Our meta-analysis shows that serum calcium is associated with SNPs in or near the calcium-sensing receptor (CASR) gene on 3q13. The top hit with a p-value of 6.3×10
-37 is rs1801725, a missense variant, explaining 1.26% of the variance in serum calcium. This SNP had the strongest association in individuals of European descent, while for individuals of Indian Asian descent the top hit was rs17251221 (p = 1.1×10-21 ), a SNP in strong linkage disequilibrium with rs1801725. The strongest locus in CASR was shown to replicate in an independent Icelandic cohort of 4,126 individuals (p = 1.02×10-4 ). This genome-wide meta-analysis shows that common CASR variants modulate serum calcium levels in the adult general population, which confirms previous results in some candidate gene studies of the CASR locus. This study highlights the key role of CASR in calcium regulation. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
34. Several common variants modulate heart rate, PR interval and QRS duration.
- Author
-
Holm, Hilma, Gudbjartsson, Daniel F., Arnar, David O., Thorleifsson, Gudmar, Thorgeirsson, Gudmundur, Stefansdottir, Hrafnhildur, Gudjonsson, Sigurjon A., Jonasdottir, Aslaug, Mathiesen, Ellisiv B., Njølstad, Inger, Nyrnes, Audhild, Wilsgaard, Tom, Hald, Erin M., Hveem, Kristian, Stoltenberg, Camilla, Løchen, Maja-Lisa, Kong, Augustine, Thorsteinsdottir, Unnur, and Stefansson, Kari
- Subjects
ELECTROCARDIOGRAPHY ,HEART conduction system ,HEART beat ,GENOMICS ,LOCUS (Genetics) ,ATRIAL fibrillation ,CARDIOVASCULAR diseases - Abstract
Electrocardiographic measures are indicative of the function of the cardiac conduction system. To search for sequence variants that modulate heart rate, PR interval and QRS duration in individuals of European descent, we performed a genome-wide association study in ∼10,000 individuals and followed up the top signals in an additional ∼10,000 individuals. We identified several genome-wide significant associations (with P < 1.6 × 10
−7 ). We identified one locus for heart rate (MYH6), four for PR interval (TBX5, SCN10A, CAV1 and ARHGAP24) and four for QRS duration (TBX5, SCN10A, 6p21 and 10q21). We tested for association between these loci and subjects with selected arrhythmias in Icelandic and Norwegian case-control sample sets. We observed correlations between TBX5 and CAV1 and atrial fibrillation (P = 4.0 × 10−5 and P = 0.00032, respectively), between TBX5 and advanced atrioventricular block (P = 0.0067), and between SCN10A and pacemaker implantation (P = 0.0029). We also replicated previously described associations with the QT interval. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
35. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density.
- Author
-
Thorleifsson, Gudmar, Holm, Hilma, Edvardsson, Vidar, Walters, G. Bragi, Styrkarsdottir, Unnur, Gudbjartsson, Daniel F., Sulem, Patrick, Halldorsson, Bjarni V., de Vegt, Femmie, d'Ancona, Frank C. H., den Heijer, Martin, Franzson, Leifur, Christiansen, Claus, Alexandersen, Peter, Rafnar, Thorunn, Kristjansson, Kristleifur, Sigurdsson, Gunnar, Kiemeney, Lambertus A., Bodvarsson, Magnus, and Indridason, Olafur S.
- Subjects
KIDNEY diseases ,KIDNEY stones ,EPITHELIAL cells ,GENOMES ,CLINICAL trials - Abstract
Kidney stone disease is a common condition. To search for sequence variants conferring risk of kidney stones, we conducted a genome-wide association study in 3,773 cases and 42,510 controls from Iceland and The Netherlands. We discovered common, synonymous variants in the CLDN14 gene that associate with kidney stones (OR = 1.25 and P = 4.0 × 10
−12 for rs219780[C]). Approximately 62% of the general population is homozygous for rs219780[C] and is estimated to have 1.64 times greater risk of developing the disease compared to noncarriers. The CLDN14 gene is expressed in the kidney and regulates paracellular permeability at epithelial tight junctions. The same variants were also found to associate with reduced bone mineral density at the hip (P = 0.00039) and spine (P = 0.0077). [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
36. Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche.
- Author
-
Sulem, Patrick, Gudbjartsson, Daniel F., Rafnar, Thorunn, Holm, Hilma, Olafsdottir, Elinborg J., Olafsdottir, Gudridur H., Jonsson, Thorvaldur, Alexandersen, Peter, Feenstra, Bjarke, Boyd, Heather A., Aben, Katja K., Verbeek, Andre L. M., Roeleveld, Nel, Jonasdottir, Aslaug, Styrkarsdottir, Unnur, Steinthorsdottir, Valgerdur, Karason, Ari, Stacey, Simon N., Gudmundsson, Julius, and Jakobsdottir, Margret
- Subjects
GENOMES ,MENARCHE ,ADIPOSE tissues ,DNA replication ,BODY mass index - Abstract
Earlier menarche correlates with shorter adult height and higher childhood body fat. We conducted a genome-wide association study of age at menarche (AAM) on 15,297 Icelandic women. Combined analysis with replication sets from Iceland, Denmark and the Netherlands (N = 10,040) yielded a significant association between rs314280[T] on 6q21, near the LIN28B gene, and AAM (effect = 1.2 months later per allele; P = 1.8 × 10
−14 ). A second SNP within the same linkage disequilibrium (LD) block, rs314277, splits rs314280[T] into two haplotypes with different effects (0.9 months and 1.9 months per allele). These variants have been associated with greater adult height. The association with adult height did not account for the association with AAM or vice versa. Other variants, previously associated with height, did not associate significantly with AAM. Given the link between body fat and AAM, we also assessed 11 variants recently associated with higher body mass index (BMI) and 5 of those associated with earlier AAM. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
37. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke.
- Author
-
Gretarsdottir, Solveig, Thorleifsson, Gudmar, Manolescu, Andrei, Styrkarsdottir, Unnur, Helgadottir, Anna, Gschwendtner, Andreas, Kostulas, Konstantinos, Kuhlenbäumer, Gregor, Bevan, Steve, Jonsdottir, Thorbjorg, Bjarnason, Hjordis, Saemundsdottir, Jona, Palsson, Stefan, Arnar, David O., Holm, Hilma, Thorgeirsson, Gudmundur, Valdimarsson, Einar Mar, Sveinbjörnsdottir, Sigurlaug, Gieger, Christian, and Berger, Klaus
- Abstract
Copyright of Annals of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2008
- Full Text
- View/download PDF
38. Variants conferring risk of atrial fibrillation on chromosome 4q25.
- Author
-
Gudbjartsson, Daniel F., Arnar, David O., Helgadottir, Anna, Gretarsdottir, Solveig, Holm, Hilma, Sigurdsson, Asgeir, Jonasdottir, Adalbjorg, Baker, Adam, Thorleifsson, Gudmar, Kristjansson, Kristleifur, Palsson, Arnar, Blondal, Thorarinn, Sulem, Patrick, Backman, Valgerdur M., Hardarson, Gudmundur A., Palsdottir, Ebba, Helgason, Agnar, Sigurjonsdottir, Runa, Sverrisson, Jon T., and Kostulas, Konstantinos
- Subjects
ATRIAL fibrillation ,ATRIAL arrhythmias ,HEART diseases ,MORTALITY ,GENOMES ,GENETICS - Abstract
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans and is characterized by chaotic electrical activity of the atria. It affects one in ten individuals over the age of 80 years, causes significant morbidity and is an independent predictor of mortality. Recent studies have provided evidence of a genetic contribution to AF. Mutations in potassium-channel genes have been associated with familial AF but account for only a small fraction of all cases of AF. We have performed a genome-wide association scan, followed by replication studies in three populations of European descent and a Chinese population from Hong Kong and find a strong association between two sequence variants on chromosome 4q25 and AF. Here we show that about 35% of individuals of European descent have at least one of the variants and that the risk of AF increases by 1.72 and 1.39 per copy. The association with the stronger variant is replicated in the Chinese population, where it is carried by 75% of individuals and the risk of AF is increased by 1.42 per copy. A stronger association was observed in individuals with typical atrial flutter. Both variants are adjacent to PITX2, which is known to have a critical function in left–right asymmetry of the heart. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
39. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke.
- Author
-
Gudbjartsson, Daniel F., Holm, Hilma, Gretarsdottir, Solveig, Thorleifsson, Gudmar, Walters, G. Bragi, Thorgeirsson, Gudmundur, Gulcher, Jeffrey, Mathiesen, Ellisiv B., Njølstad, Inger, Nyrnes, Audhild, Wilsgaard, Tom, Hald, Erin M., Hveem, Kristian, Stoltenberg, Camilla, Kucera, Gayle, Stubblefield, Tanya, Carter, Shannon, Roden, Dan, Ng, Maggie C. Y., and Baum, Larry
- Subjects
ATRIAL fibrillation ,CEREBROVASCULAR disease ,NUCLEOTIDE sequence ,CHROMOSOMES ,CLINICAL trials - Abstract
We expanded our genome-wide association study on atrial fibrillation (AF) in Iceland, which previously identified risk variants on 4q25, and tested the most significant associations in samples from Iceland, Norway and the United States. A variant in the ZFHX3 gene on chromosome 16q22, rs7193343-T, associated significantly with AF (odds ratio OR = 1.21, P = 1.4 × 10
−10 ). This variant also associated with ischemic stroke (OR = 1.11, P = 0.00054) and cardioembolic stroke (OR = 1.22, P = 0.00021) in a combined analysis of five stroke samples. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
40. MEPE loss-of-function variant associates with decreased bone mineral density and increased fracture risk.
- Author
-
Surakka, Ida, Fritsche, Lars G., Zhou, Wei, Backman, Joshua, Kosmicki, Jack A., Lu, Haocheng, Brumpton, Ben, Nielsen, Jonas B., Gabrielsen, Maiken E., Skogholt, Anne Heidi, Wolford, Brooke, Graham, Sarah E., Chen, Y. Eugene, Lee, Seunggeun, Kang, Hyun Min, Langhammer, Arnulf, Forsmo, Siri, Åsvold, Bjørn O., Styrkarsdottir, Unnur, and Holm, Hilma
- Subjects
BONE density ,HEEL bone ,HUMAN genome ,GENE frequency ,INDIVIDUALIZED medicine ,FOREARM - Abstract
A major challenge in genetic association studies is that most associated variants fall in the non-coding part of the human genome. We searched for variants associated with bone mineral density (BMD) after enriching the discovery cohort for loss-of-function (LoF) mutations by sequencing a subset of the Nord-Trøndelag Health Study, followed by imputation in the remaining sample (N = 19,705), and identified ten known BMD loci. However, one previously unreported variant, LoF mutation in MEPE, p.(Lys70IlefsTer26, minor allele frequency [MAF] = 0.8%), was associated with decreased ultradistal forearm BMD (P-value = 2.1 × 10
−18 ), and increased osteoporosis (P-value = 4.2 × 10−5 ) and fracture risk (P-value = 1.6 × 10−5 ). The MEPE LoF association with BMD and fractures was further evaluated in 279,435 UK (MAF = 0.05%, heel bone estimated BMD P-value = 1.2 × 10−16 , any fracture P-value = 0.05) and 375,984 Icelandic samples (MAF = 0.03%, arm BMD P-value = 0.12, forearm fracture P-value = 0.005). Screening for the MEPE LoF mutations before adulthood could potentially prevent osteoporosis and fractures due to the lifelong effect on BMD observed in the study. A key implication for precision medicine is that high-impact functional variants missing from the publicly available cosmopolitan panels could be clinically more relevant than polygenic risk scores. Bone mineral density (BMD) is associated with fracture risk and many genetic loci with small effect sizes have been discovered by genome-wide association studies (GWAS). Here, the authors discover a large-effect rare loss-of-function genetic variant for BMD in the MEPE gene in the Norwegian HUNT study which replicates in the UK Biobank. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
41. A truncating mutation in EPOR leads to hypo-responsiveness to erythropoietin with normal haemoglobin.
- Author
-
Oskarsson, Gudjon R., Kristjansson, Ragnar P., Lee, Amy L., Sveinbjornsson, Gardar, Magnusson, Magnus K., Ivarsdottir, Erna V., Benonisdottir, Stefania, Oddsson, Asmundur, Davidsson, Olafur B., Saemundsdottir, Jona, Halldorsson, Gisli H., Arthur, Joseph, Arnadottir, Gudny A., Masson, Gisli, Jensson, Brynjar O., Holm, Hilma, Olafsson, Isleifur, Onundarson, Pall T., Gudbjartsson, Daniel F., and Norddahl, Gudmundur L.
- Subjects
ERYTHROPOIETIN ,CELLULAR signal transduction ,ERYTHROCYTES ,GENETIC mutation ,HEMOGLOBINS - Abstract
The cytokine erythropoietin (EPO), signalling through the EPO receptor (EPO-R), is essential for the formation of red blood cells. We performed a genome-wide association study (GWAS) testing 32.5 million sequence variants for association with serum EPO levels in a set of 4187 individuals. We detect an association between a rare and well imputed stop-gained variant rs370865377[A] (p.Gln82Ter) in EPOR, carried by 1 in 550 Icelanders, and increased serum EPO levels (MAF = 0.09%, Effect = 1.47 SD, P = 3.3 × 10
−7 ). We validated these findings by measuring serum EPO levels in 34 additional pairs of carriers and matched controls and found carriers to have 3.23-fold higher EPO levels than controls (P = 1.7 × 10−6 ; Pcombined = 1.6 × 10−11 ). In contrast to previously reported EPOR mutations, p.Gln82Ter does not associate with haemoglobin levels (Effect = −0.045 SD, P = 0.32, N = 273,160), probably due to a compensatory EPO upregulation in response to EPO-R hypo-responsiveness. Gudjon Oskarsson et al. report the association of a rare variant in the erythropoietin (EPO) receptor gene, EPOR, with serum EPO levels in the Icelandic population. The variant leads to a truncation of EPO-R without an effect on hemoglobin levels, indicating a possible feedback mechanism in the generation of red blood cells. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
42. Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.
- Author
-
Gudmundsson, Julius, Sigurdsson, Jon K., Stefansdottir, Lilja, Agnarsson, Bjarni A., Isaksson, Helgi J., Stefansson, Olafur A., Gudjonsson, Sigurjon A., Gudbjartsson, Daniel F., Masson, Gisli, Frigge, Michael L., Stacey, Simon N., Sulem, Patrick, Halldorsson, Gisli H., Tragante, Vinicius, Holm, Hilma, Eyjolfsson, Gudmundur I., Sigurdardottir, Olof, Olafsson, Isleifur, Jonsson, Thorvaldur, and Jonsson, Eirikur
- Abstract
Benign prostatic hyperplasia and associated lower urinary tract symptoms (BPH/LUTS) are common conditions affecting the majority of elderly males. Here we report the results of a genome-wide association study of symptomatic BPH/LUTS in 20,621 patients and 280,541 controls of European ancestry, from Iceland and the UK. We discovered 23 genome-wide significant variants, located at 14 loci. There is little or no overlap between the BPH/LUTS variants and published prostate cancer risk variants. However, 15 of the variants reported here also associate with serum levels of prostate specific antigen (PSA) (at a Bonferroni corrected P < 0.0022). Furthermore, there is a strong genetic correlation, r
g = 0.77 (P = 2.6 × 10−11 ), between PSA and BPH/LUTS, and one standard deviation increase in a polygenic risk score (PRS) for BPH/LUTS increases PSA levels by 12.9% (P = 1.6×10−55 ). These results shed a light on the genetic background of BPH/LUTS and its substantial influence on PSA levels. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
43. Abstract 15122: Use of Genetic Information in Attempt to Modify the Risk of Sudden Cardiac Death by Screening the Icelandic Population for Variants Associating With the Long QT-Syndrome.
- Author
-
Benediktsdottir, Bára D, Sveinbjornsson, Gardar, Sigfússon, Gunnlaugur, Guðbjartsson, Daníel, Holm, Hilma, Arnar, David O, and Stefánsson, Kári
- Published
- 2018
44. Epigenetic and genetic components of height regulation.
- Author
-
Benonisdottir, Stefania, Oddsson, Asmundur, Helgason, Agnar, Kristjansson, Ragnar P., Sveinbjornsson, Gardar, Oskarsdottir, Arna, Thorleifsson, Gudmar, Davidsson, Olafur B., Arnadottir, Gudny A., Sulem, Gerald, Jensson, Brynjar O., Holm, Hilma, Alexandersson, Kristjan F., Tryggvadottir, Laufey, Walters, G. Bragi, Gudjonsson, Sigurjon A., Ward, Lucas D., Sigurdsson, Jon K., Iordache, Paul D., and Frigge, Michael L.
- Published
- 2016
- Full Text
- View/download PDF
45. Common and rare variants associating with serum levels of creatine kinase and lactate dehydrogenase.
- Author
-
Kristjansson, Ragnar P., Oddsson, Asmundur, Helgason, Hannes, Sveinbjornsson, Gardar, Arnadottir, Gudny A., Jensson, Brynjar O., Jonasdottir, Aslaug, Jonasdottir, Adalbjorg, Bragi Walters, G., Sulem, Gerald, Oskarsdottir, Arna, Benonisdottir, Stefania, Davidsson, Olafur B., Masson, Gisli, Th Magnusson, Olafur, Holm, Hilma, Sigurdardottir, Olof, Jonsdottir, Ingileif, Eyjolfsson, Gudmundur I., and Olafsson, Isleifur
- Published
- 2016
- Full Text
- View/download PDF
46. Common and rare variants associated with kidney stones and biochemical traits.
- Author
-
Oddsson, Asmundur, Sulem, Patrick, Helgason, Hannes, Edvardsson, Vidar O., Thorleifsson, Gudmar, Sveinbjörnsson, Gardar, Haraldsdottir, Eik, Eyjolfsson, Gudmundur I., Sigurdardottir, Olof, Olafsson, Isleifur, Masson, Gisli, Holm, Hilma, Gudbjartsson, Daniel F., Thorsteinsdottir, Unnur, Indridason, Olafur S., Palsson, Runolfur, and Stefansson, Kari
- Published
- 2015
- Full Text
- View/download PDF
47. Genetic Risk Score and Cardiovascular Events in Women.
- Author
-
Holm, Hilma, Thorleifsson, Gudmar, and Stefansson, Kari
- Subjects
LETTERS to the editor ,CARDIOVASCULAR diseases - Abstract
A letter to the editor is presented in response to the article "Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in Women," by Nina P. Paynter and colleagues in the 2010 issue.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.